![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hovione Farmaciencia S.a. Loures Pt, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Fluticasone propionate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-160 - Rev 02
This Chemical Type CEP, issued on February 27, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1750 associated with this CEP further emphasizes